Clinical Trial

Minnesota RETAIN Phase 3

Study acronym: MN RETAIN
Recruiting
View on ClinicalTrials.gov →
Summary
MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), and stakeholders throughout MN. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic a subrecipients of the grant.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-17; most recent amendment 2025-10-29.
Status change: Not Yet Recruiting → Recruiting 2025-07-01
Trial Details
NCT Number NCT07037927
Lead Sponsor Mayo Clinic
Collaborators: Minnesota Department of Employment and Economic Development, U.S. Department of Education
Conditions Injuries Related Work, Illness Related Work, Disability
Enrollment 1,000 participants
Start Date 2025-07-07
Primary Completion 2028-03-31 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-30